
Sight Sciences Appoints Gary Burbach to Board of Directors
Published on April 23, 2025
MENLO PARK, Calif—Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company that develops and commercializes innovative, interventional technologies to elevate the standard of care, has announced that Gerhard (Gary) F. Burbach has been appointed to the company’s board of directors, effective April 21, 2025. Burbach will serve as a class II director, with a term expiring at the 2026 annual meeting of stockholders, the company stated, noting that he brings extensive experience to his position on the board.
